NSC |
Compound |
Enrichment |
Correlation |
NSC 301457 |
Cycloalkannin |
0.0193573267900279 |
0.11532525 |
NSC 363787 |
Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- |
0.0193573267900279 |
0.21056436 |
NSC 618759 |
4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide |
0.0193573267900279 |
0.17527268 |
NSC 620327 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.0193573267900279 |
-0.094655597 |
NSC 633207 |
Null |
0.0193573267900279 |
0.32206278 |
NSC 639514 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride |
0.0193573267900279 |
0.30870229 |
NSC 639520 |
Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride |
0.0193573267900279 |
0.17836206 |
NSC 639541 |
Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- |
0.0193573267900279 |
0.3246995 |
NSC 641245 |
Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- |
0.0193573267900279 |
0.39458228 |
NSC 659390 |
Null |
0.0193573267900279 |
0.12553138 |